Clinical Trial Update: Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the efficacy, safety and anti-inflammatory effect of topical cyclosporine A 0.05% emulsion versus REFRESH artificial tears in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• REFRESH®
• Topical cyclosporine A 0.05% emulsion (cyclosporine A)

Snippet

Sponsor: Chulalongkorn University | Conditions: Dry Eye | Phase 4 | Status: UNKNOWN